WASHINGTON, D.C. – The Food and Drug Administration announced Saturday that it has authorized an at-home sample collection kit that can then be sent to specified laboratories for COVID-19 diagnostic testing.
Specifically, the FDA issued an emergency use authorization (EUA) to Everlywell, Inc. for the Everlywell COVID-19 Test Home Collection Kit.
Everlywell’s kit is authorized to be used by individuals at home who have been screened using an online questionnaire that is reviewed by a health care provider. This allows an individual to self-collect a nasal sample at home using Everlywell’s authorized kit.